Skip to main content

Advertisement

Log in

Ectoparasitic infestations

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Ectoparasitic infestations are highly prevalent in resourcepoor populations throughout the world and are associated with considerable morbidity. Reliable data on the epidemiology, immunology, and therapy of ectoparasitic infestations and on the biology of the parasites remain scarce. The control of parasitic skin diseases, such as scabies, pediculosis, tungiasis, myiasis, and cutaneous larva migrans in endemic areas remains a challenge. Using appropriate study designs, it is imperative to increase further the knowledge on the various aspects of the parasites and the infestations they cause.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References and Recommended Reading

  1. Hoy W, McDonald SP: Albuminuria: marker or target in indigenous populations. Kidney Int Suppl 2004, 66:25–31.

    Article  Google Scholar 

  2. Arlian LG, Morgan MS, Estes SA, et al.: Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol 2004, 41:74–77.

    PubMed  Google Scholar 

  3. Lowenstein M, Kahlbacher H, Peschke R: On the substantial variation in serological responses in pigs to Sarcoptes scabiei var. suis using different commercially available indirect enzyme-linked immunosorbent assays. Parasitol Res 2004, 94:24–30.

    Article  PubMed  CAS  Google Scholar 

  4. Haas N, Wagemann B, Hermes B, et al.: Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch Dermatol Res 2005, 296:327–331.

    Article  PubMed  CAS  Google Scholar 

  5. Walton S, Low Choy J, Bonson A, et al.: Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabiesendemic communities in northern Australia. Am J Trop Med Hyg 1999, 61:542–547.

    PubMed  CAS  Google Scholar 

  6. Walton SF, Dougall A, Pizzutto S, et al.: Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int J Parsitol 2004, 34:839–849.

    Article  CAS  Google Scholar 

  7. Ambroise-ThomasP: Emerging parasite zoonoses: the role of host-parasite relationship. Int J Parasitol 2000, 30:1361–1367.

    Article  PubMed  CAS  Google Scholar 

  8. Harumal P, Morgan MS, Walton SF, et al.: Identification of a homologue of a house dust mite allergen in a cDNA library from Sarcoptes scabiei var. hominis and evaluation of its vaccine potential in a rabbit/S. scabiei var. canis model. Am J Trop Med Hyg 2003, 68:54–60.

    PubMed  CAS  Google Scholar 

  9. Roberts LJ, Huffam SE, Walton SF, Currie BJ: Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005, 50:375–381.

    Article  PubMed  CAS  Google Scholar 

  10. Walton SF, Holt DC: Scabies: new future for a neglected disease. Adv Parasitol 2004, 57:309–376. This comprehensive review highlights recent advances in the study and control of scabies in human and veterinary medicine.

    Article  PubMed  Google Scholar 

  11. Tielsch JM, Beeche A: Impact of ivermectin on illness and disability associated with onchocerciasis. Trop Med Int Health 2004, 9:45–56.

    Article  Google Scholar 

  12. Heukelbach J, Winter B, Wilcke T, et al.: Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 2004, 82:563–571.

    PubMed  Google Scholar 

  13. Lawrence G, Leafasia J, Sheridan J, et al.: Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 2005, 83:34–42.

    PubMed  Google Scholar 

  14. Currie BJ, Harumal P, McKinnon M, Walton SF: First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004, 39:8–12.

    Article  Google Scholar 

  15. Micali G, Lacarrubba F, Tedeschi A: Videodermatoscopy enhances the ability to monitor efficacy of scabies treatment and allows optimal timing of drug application. J Eur Acad Dermatol Venereol 2004, 18:153–154.

    Article  PubMed  CAS  Google Scholar 

  16. Morsy TA, Rahem MA, el-Sharkawy EM, Shatat MA: Eucalyptus globulus (camphor oil) against the zoonotic scabies, Sarcoptes scabiei. J Egypt Soc Parasitol 2003, 33:47–53.

    PubMed  Google Scholar 

  17. Walton SF, McKinnon M, Pizzutto S, et al.: Acaricidal activity of Melaleuca alternifolia (Tea Tree) oil: in vitro sensitivity of Sarcoptes scabiei var. hominis to terpinen-4-ol. Arch Dermatol 2004, 140:563–566.

    Article  PubMed  CAS  Google Scholar 

  18. Fischer K, Holt DC, Harumal P, et al.: Generation and characterisation of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg 2003, 68:61–64.

    PubMed  CAS  Google Scholar 

  19. Ljunggren EL, Nilsson D, Mattsson JG: Expressed sequence tag analysis of Sarcoptes scabiei. Parasitology 2003, 127:139–145.

    Article  PubMed  CAS  Google Scholar 

  20. Holt DC, Fischer K, Allen GE, et al.: Mechanisms for a novel immune evasion strategy in the scabies mite Sarcoptes scabiei: A multigene family of inactivated serine proteases. J Invest Dermatol 2003, 121:1419–1424.

    Article  PubMed  CAS  Google Scholar 

  21. Holt DC, Fischer K, Pizzutto SJ, et al.: A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J Invest Dermatol 2004, 123:240–241.

    Article  PubMed  CAS  Google Scholar 

  22. Pettersson EU, Ljunggren EL, Morrison DA, Mattsson JG: Functional analysis and localisation of a delta-class glutathione S-transferase from Sarcoptes scabiei. Int J Parasitol 2005, 35:39–48.

    Article  PubMed  CAS  Google Scholar 

  23. Hansen RC, O’Haver J: Economic considerations associated with Pediculus humanus capitis infestation. Clin Pediatr (Phila) 2004, 43:523–527.

    Article  Google Scholar 

  24. Heukelbach J, Wilcke T, Winter B, Feldmeier H: Epidemiology and morbidity of scabies and pediculosis capitis in resourcepoor communities in northeast Brazil. Br J Dermatol 2005, 153:150–156. Epidemiologic data on scabies and pediculosis from longitudinal studies in resource-poor communities are presented in this article.

    Article  PubMed  CAS  Google Scholar 

  25. DownsAM: Managing head lice in an era of increasing resistance to insecticides. Am J Clin Dermatol 2004, 5:169–177. This article is a review of current pediculicides, resistance, and management of head lice.

    Article  PubMed  Google Scholar 

  26. Counahan M, Andrews R, Buttner P, et al.: Head lice prevalence in primary schools in Victoria, Australia. J Paediatr Child Health 2004, 40:616–619.

    Article  PubMed  CAS  Google Scholar 

  27. Yang YC, Lee HS, Clark JM, Ahn YJ: Insecticidal activity of plant essential oils against Pediculus humanus capitis (Anoplura: Pediculidae). J Med Entomol 2004, 41:699–704.

    Article  PubMed  CAS  Google Scholar 

  28. Yang YC, Choi HY, Choi WS, et al.: Ovicidal and adulticidal activity of Eucalyptus globulus leaf oil terpenoids against Pediculus humanus capitis (Anoplura: Pediculidae). J Agric Food Chem 2004, 52:2507–2511.

    Article  PubMed  CAS  Google Scholar 

  29. Mumcuoglu KY, Magdassi S, Miller J, et al.: Repellency of citronella for head lice: double-blind randomized trial of efficacy and safety. Isr Med Assoc J 2004, 6:756–759.

    PubMed  Google Scholar 

  30. Mills C, Cleary BJ, Gilmer JF, Walsh JJ: Inhibition of acetylcholinesterase by Tea Tree oil. J Pharm Pharmacol 2004, 56:375–379.

    Article  PubMed  CAS  Google Scholar 

  31. Takano-Lee M, Edman JD, Mullens BA, Clark JM: Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis (Anoplura: Pediculidae). J Pediatr Nurs 2004, 19:393–398.

    Article  PubMed  Google Scholar 

  32. Pedra JH, Brandt A, Li HM, et al.: Transcriptome identification of putative genes involved in protein catabolism and innate immune response in human body louse (Pediculicidae: Pediculus humanus). Insect Biochem Mol Biol 2003, 33:1135–1143.

    Article  PubMed  CAS  Google Scholar 

  33. Kollien AH, Waniek PJ, Prols F, et al.: Cloning and characterization of a trypsin-encoding cDNA of the human body louse Pediculus humanus. Insect Mol Biol 2004, 13:9–18.

    Article  PubMed  CAS  Google Scholar 

  34. Perotti MA, Catala SS, Ormeno Adel V, et al.: The sex ratio distortion in the human head louse is conserved over time. BMC Genet 2004, 5:10.

    Article  PubMed  Google Scholar 

  35. Taylor MJ, Hoerauf A: A new approach to the treatment of filariasis. Curr Opin Infect Dis 2001, 14:727–731.

    PubMed  CAS  Google Scholar 

  36. Hise AG, Gillette-Ferguson I, Pearlman E: The role of endosymbiotic Wolbachia bacteria in filarial disease. Cell Microbiol 2004, 6:97–104.

    Article  PubMed  CAS  Google Scholar 

  37. Shashindran CH, Gandhi IS, Krishnasamy S, Ghosh MN: Oral therapy of pediculosis capitis with cotrimoxazole. Br J Dermatol 1978, 98:699–700.

    Article  PubMed  CAS  Google Scholar 

  38. Witt LH, Linardi PM, Meckes O, et al.: Blood-feeding of Tunga penetrans males. Med Vet Entomol 2004, 18:439–441.

    Article  PubMed  CAS  Google Scholar 

  39. Feldmeier H, Heukelbach J, Eisele M, et al.: Bacterial superinfection in human tungiasis. Trop Med Int Health 2002, 7:559–564.

    Article  PubMed  CAS  Google Scholar 

  40. Franck S, Feldmeier H, Heukelbach J: Tungiasis: more than an exotic nuisance. Travel Med Infect Dis 2003, 1:159–166. This article provides a comprehensive review on all aspects of tungiasis.

    Article  PubMed  Google Scholar 

  41. Veraldi S, Carrera C, Schianchi R: Tungiasis has reached Europe. Dermatology 2000, 201:382.

    Article  PubMed  CAS  Google Scholar 

  42. Muehlen M, Feldmeier H, Wilcke T, et al.: Identifying risk factors for tungiasis and heavy infestation in a resource-poor community in Northeast Brazil. Trans Roy Soc Trop Med Hyg 2005, In press.

  43. Heukelbach J, Costa AML, Wilcke T, et al.: The animal reservoir of Tunga penetrans in severely affected communities of north-east Brazil. Med Vet Entomol 2004, 18:329–335.

    Article  PubMed  CAS  Google Scholar 

  44. Heukelbach J, Wilcke T, Harms G, Feldmeier H: Seasonal variation of tungiasis in an endemic community. Am J Trop Med Hyg 2005, 72:145–149.

    PubMed  Google Scholar 

  45. Eisele M, Heukelbach J, van Marck E, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: I. Natural history of tungiasis in man. Parasitol Res 2003, 90:87–99. This review provides a detailed clinical and microscopic description of the natural history of tungiasis.

    PubMed  Google Scholar 

  46. Heukelbach J, Franck S, Feldmeier H: Therapy of tungiasis: a double-blinded randomized controlled trial with oral ivermectin. Mem Inst Oswaldo Cruz 2004, 99:873–876.

    Article  PubMed  CAS  Google Scholar 

  47. Heukelbach J, Eisele M, Jackson A, Feldmeier H: Topical treatment of tungiasis: a randomized, controlled trial. Ann Trop Med Parasitol 2003, 97:743–749.

    Article  PubMed  CAS  Google Scholar 

  48. Schwalfenberg S, Witt LH, Kehr JD, et al.: Prevention of tungiasis using a biological repellent: a small case series. Ann Trop Med Parasitol 2004, 98:89–94.

    Article  PubMed  CAS  Google Scholar 

  49. Heukelbach J, Bonow I, Witt LH, et al.: High infection rate of Wolbachia endobacteria in the sand flea Tunga penetrans from Brazil. Acta Trop 2004, 92:225–230.

    Article  PubMed  Google Scholar 

  50. Feldmeier H, Witt LH, Schwalfenberg S, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil V. Cytokine concentrations in experimentally infected Wistar rats. Parasitol Res 2004, 94:371–376.

    Article  PubMed  Google Scholar 

  51. Feldmeier H, Heukelbach J, Eisele M, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: III. Cytokine levels in peripheral blood of infected humans. Parasitol Res 2003, 91:298–303.

    Article  PubMed  Google Scholar 

  52. Pampiglione S, Trentini M, Fioravanti ML, Gustinelli A: Differential diagnosis between Tunga penetrans (L., 1758) and T. trimamillata Pampiglione et al., 2002 (Insecta, Siphonaptera), the two species of the genus Tunga parasitic in man. Parasite 2004, 11:51–57.

    PubMed  CAS  Google Scholar 

  53. Vobis M, D’Haese J, Mehlhorn H, et al.: Molecular biological investigations of Brazilian Tunga sp. isolates from man, dogs, cats, pigs and rats. Parasitol Res 2005, 96:107–112.

    Article  PubMed  CAS  Google Scholar 

  54. Heukelbach J, Wilcke T, Meier A, et al.: A longitudinal study on cutaneous larva migrans in an impoverished Brazilian township. Travel Med Infect Dis 2003, 1:213–218. This study provides evidence for a strong seasonal variation of cutaneous larva migrans.

    Article  PubMed  Google Scholar 

  55. Heukelbach J, Wilcke T, Feldmeier H: Cutaneous larva migrans (creeping eruption) in an urban slum in Brazil. Int J Dermatol 2004, 43:511–515.

    Article  PubMed  Google Scholar 

  56. Tremblay A, MacLean JD, Gyorkos T, Macpherson DW: Outbreak of cutaneous larva migrans in a group of travelers. Trop Med Int Health 2000, 5:330–334.

    Article  PubMed  CAS  Google Scholar 

  57. CaumesE: Treatment of cutaneous larva migrans and Toxocara infection. Fundam Clin Pharmacol 2003, 17:213–216.

    Article  PubMed  CAS  Google Scholar 

  58. de Barros N, D’Avila MS, de Pace BS, et al.: Cutaneous myiasis of the breast: mammographic and us features-report of five cases. Radiology 2001, 218:517–520.

    PubMed  Google Scholar 

  59. Quintanilla-Cedillo MR, Leon-Urena H, Contreras-Ruiz J, Arenas R: The value of Doppler ultrasound in diagnosis in 25 cases of furunculoid myiasis. Int J Dermatol 2005, 44:34–37.

    Article  PubMed  Google Scholar 

  60. OtrantoD: The immunology of myiasis: parasite survival and host defense strategies. Trends Parasitol 2001, 17:176–182.

    Article  PubMed  CAS  Google Scholar 

  61. Otranto D, Stevens JR: Molecular approaches to the study of myiasis-causing larvae. Int J Parasitol 2002, 32:1345–1360. This is a comprehensive overview on the taxonomy, biology, and molecular characterization of fly larvae responsible for human and animal myiases.

    Article  PubMed  CAS  Google Scholar 

  62. Norwood C, Smith KJ, Neafie R, Skelton H: Are cutaneous reactions to fly larvae mediated by CD4+, TIA+ NK1.1 T Cells? J Cutan Med Surg 2001, 5:400–405.

    Article  PubMed  CAS  Google Scholar 

  63. Costa DC, de Tarso Ponte Pierre-Filho, Mac Cord Medina F, Mota RG, Carrera CR: Use of oral ivermectin in a patient with destructive rhino-orbital myiasis. Eye 2005, In press.

  64. De Tarso P, Pierre-Filho P, Minguini N, et al.: Use of ivermectin in the treatment of orbital myiasis caused by Cochliomyia hominivorax. Scand J Infect Dis 2004, 36:503–505.

    Article  PubMed  Google Scholar 

  65. Nuesch R, Rahm G, Rudin W, et al.: Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection 2002, 30:306–309.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heukelbach, J., Walton, S.F. & Feldmeier, H. Ectoparasitic infestations. Curr Infect Dis Rep 7, 373–380 (2005). https://doi.org/10.1007/s11908-005-0012-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-005-0012-2

Keywords